lmp1/2 ctls
Cell therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2007 (NCT00062868)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Latent membrane protein 1Immunity, passive
LMP1 immunity, passive
- Proteasome subunit beta type-9Immunity, passive
PSMB9 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- lmp1/2 ctls
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01956084 | Phase 1 | Nov 1, 2013 | Children's National Medical Center |
| NCT00062868 | Phase 1 | Apr 1, 2007 | Baylor University, Methodist Cancer Center, Houston, Texas |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Baylor University | Academic/Hospital | 1 | 1 | 1 | 2007 |
| Children's National Medical Center | Academic/Hospital | 1 | 1 | 1 | 2013 |
| Methodist Cancer Center, Houston, Texas | Academic/Hospital | 1 | 0 | 1 | 2007 |
3 organizations
Page 1 / 1